Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
14,965,850
-
Total 13F shares
-
1,842,038
-
Share change
-
-201,774
-
Total reported value
-
$4,363,682
-
Price per share
-
$2.37
-
Number of holders
-
20
-
Value change
-
-$463,905
-
Number of buys
-
4
-
Number of sells
-
12
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q4 2024
As of 31 Dec 2024 CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) had 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,842,038 shares of stock of the company.
Largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, ACADIAN ASSET MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., TWO SIGMA INVESTMENTS, LP, and STATE STREET CORP.
This table shows 20 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.